Status:
RECRUITING
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Urinary Tract Infections
Eligibility:
All Genders
18+ years
Brief Summary
Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increa...
Eligibility Criteria
Inclusion
- Adult (≥18 years old)
- Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
- Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
- The subject's primary care physician agreeing to participate in the study
Exclusion
- Subject and/or their primary care physician having expressed their opposition to participating in the study
- Subject under legal protection
- Subject under guardianship or curatorship
Key Trial Info
Start Date :
October 24 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 24 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06910878
Start Date
October 24 2024
End Date
December 24 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg
Strasbourg, France